Delivery Order SPE2DB20D3103-SPE2DB24FM7X8

Award Date 2/23/24
Potential Completion Date 2/26/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM7X8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of February 26, 2024. The contract is a firm fixed price delivery order with a potential value of $4,681.55. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering the pharmaceutical product to support military treatment programs and facilities under the purview of the Department of Defense. The company has received numerous federal contract awards from DLA Troop Support Medical for pharmaceutical and medical supply products and distribution services.

Generated 5/24/24, 10:55 AM